EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Significant role of Loss or Reduced BRCA1 gene expression in clinical implication of ovarian cancer

Thekra Al-Kashwan, Furgan Al-Bedairi, Rihab Al-Midhaffer

Kufa Medical Journal · 2021

DOI: 10.36330/kmj.v17i1.1950 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Kufa Medical Journal, 2021. Verfasst von Thekra Al-Kashwan und 2 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

BRCA1 immunohistochemistry (IHC) provides a rapid initial screen to detect BRCA1 dysfunction in ovarian cancer that resulting from genetic alterations.

Aim

To assess the expression of BRCA1 protein by IHC analysis among a group of Iraqi ovarian cancer patients to evaluate the patterns of expression and its correlation with the clinicopathological parameters in attempting to evaluate a significance role of BRCA1 gene implication in ovarian cancer.

Methods

Forty three paraffin embedded samples of ovarian cancer cases were analyzed for BRCA1dysfunction by IHC analysis. The semi-quantitative approach using modified histochemical score (H-score) was achieved to assess the patterns of BRCA1 gene expression.

Results

Complete loss of BRCA1 nuclear expression was detected in 30.2% of the cases while, reduced expression occurred in 46.5% of cases, giving rise to 76.7% of all cases detected with altered BRCA1 nuclear expression. Altered BRCA1 expression was found to be higher in age group ≤ 45 years (78.3%) in comparison with those of ages >45 years. Altered BRCA1 expression was significantly correlated with the high grade and with the unilateral tumor site when compared with the low grade and bilateral tumor site (P≤0.05), and was insignificantly correlated with the high stage ovarian tumors, 11.6% of cases were detected by cytoplasmic BRCA1 expression and no association was found between cytoplasmic expression and tumor grade, stage and tumor site.

Conclusion

Altered BRCA1 expression may play a significant role in the progression of ovarian cancer. Recommendation: BRCA1 IHC is a clinically useful approach to detect the BRCA1 dysfunction and the H-score assessment reflects good estimation for BRCA1expression patterns.

Zitieren

APA

Al-Kashwan, T., Al-Bedairi, F., & Al-Midhaffer, R. (2021). Significant role of Loss or Reduced BRCA1 gene expression in clinical implication of ovarian cancer. Kufa Medical Journal. https://doi.org/10.36330/kmj.v17i1.1950

Vancouver

Al-Kashwan T, Al-Bedairi F, Al-Midhaffer R. Significant role of Loss or Reduced BRCA1 gene expression in clinical implication of ovarian cancer. Kufa Medical Journal. 2021. doi:10.36330/kmj.v17i1.1950

BibTeX
@article{AlKashwan2021,
  author = {Al-Kashwan, Thekra and Al-Bedairi, Furgan and Al-Midhaffer, Rihab},
  title = {Significant role of Loss or Reduced BRCA1 gene expression in clinical implication of ovarian cancer},
  journal = {Kufa Medical Journal},
  year = {2021},
  doi = {10.36330/kmj.v17i1.1950}
}
Kostenlos starten →